Health News: The Growing Demand for Biomarkers in Diagnosis

902
0
SHARE

Portland, OR — 01/10/2018 — Biomarkers Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $30.6 billion by 2020, registering a CAGR of 16% during the period 2013 to 2020. Disease diagnostic remains the key application segment that is expected to reach $6.1 billion in 2020. However application of diagnostic biomarkers in forensics and molecular diagnostics is catching up quite significantly with latter expected to experience a growth rate of 17.6% during 2013 and 2020.

Diagnostic biomarker technology is expected to change the scenario of drug development and medical practice, as technologies are metamorphosing from traditional pathophysiology/epidemiology approach to biomarker studies such as genomics and proteomic add the analysts.

Get the PDF Sample Copy of this report

Diagnostic biomarkers though are a great tool in molecular diagnostics, is facing challenges with respect to ethical and regulatory issues as these are relat to a genomic pattern of an individual which needs to be extremely confidential.

Asia Pacific is expected to have the highest CAGR at 20.3% from 2013 to 2020.

Key Benefits For Stakeholders:

-The report offers an assessment and ranking of the factors that favor the biomarkers market growth and those factors which act as a hindrance for the growth of the market.
-Forecast period for estimating market size is from 2013 to 2020. Two historic years include 2011 and 2012.
-The report identifies top investment pockets and offers an analysis of top winning strategies for diagnostic biomarker industry.
-The report analyses the various strategies adopted by some of the key companies in the industry.
-The report tracks and analyses key innovations and patents for biomarkers in the last five years.

Click Here, To Make a Purchase Request of this Report

Companies profiled and analyzed in this report include:

-Roche Diagnostic Limited (Switzerland)
-Siemens Healthcare (Germany)
-Abbott Laboratories Inc. (U.S.)
-Thermo Fisher Scientific, Inc. (U.S.)
-Agilent Technologies Inc. (U.S.)
-Bio-Rad Laboratories Inc. (U.S.)
-Aushon BioSystem Inc. (U.S.)
-Epistem Ltd. (U.K.)
G.E. Healthcare Inc. (U.K)

Powered by WPeMatico